Inhibitors of Akt activity
US7750151B2 · kind B2 · utility
7Cited by
1References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 5, 2005 |
| Grant date | Jul 6, 2010 |
| Priority date | — |
| Expiry date | May 1, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds which contain substituted napthyridines which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.